BBLG Q2 2017 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q2 2017 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

$2M

Net Income

$1M

EPS (Diluted)

$0.02

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$829,322

Free Cash Flow

-$829,322

Stock-Based Comp.

$530,471

Balance Sheet

Total Assets

$1M

Total Liabilities

$11M

Stockholders' Equity

-$10M

Cash & Equivalents

$783,014

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	$2M	-$4M	+146.0%
Net Income	$1M	-$5M	+121.2%